FEZF1 and colorectal carcinoma: The results revealed that high-level expression of FEZF1-AS1 in CRC was significantly correlated with overall survival (Log Rank = 9.333, p = 0.002, Figure 1D) and disease-free survival (Log Rank = 9.329, p = 0.002, Figure 1E) of CRC patients.